Table 3.
Changes in inflammation indices concentration during the period of whole-body cryotherapy (WBC) treatment in the group of long-distance runners (RUN) and in the group of untrained men (UTR).
| ANOVA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | WBC | Total | RUN | UTR | PA | WBC | PA × WBC | ||
| CRP | T1 | Mean ± SD | 1.84 ± 1.93 | 2.12 ± 2.66 | 1.57 ± 0.79 | F | 0.02 | 0.83 | 0.94 |
| (mg/L) | ΔT2vsT1 | Mean (95% CI) | 0.70 (−0.74, 2.13) | −0.12 (−2.23, 1.99) | 1.51 (−0.70, 3.72) | p | 0.89 | 0.48 | 0.43 |
| ΔT3vsT1 | Mean (95% CI) | −1.23 (0.97, 2.36) | −0.59 (−2.53, 1.36) | 0.33 (−1.07, 1.73) | η2 | <0.01 | 0.04 | 0.05 | |
| ΔT4vsT1 | Mean (95% CI) | −0.93 (1.11, 2.18) | 0.06 (−2.01, 2.14) | 0.12 (−0.79, 1.02) | 1-β | 0.05 | 0.22 | 0.24 | |
| IL-6 | T1 | Mean ± SD | 1.76 ± 1.05 | 1.34 ± 0.98 | 2.18 ± 0.98 *,RUN | F | 17.72 | 1.39 | 0.70 |
| (pg/mL) | ΔT2vsT1 | Mean (95% CI) | −0.02 (−0.52, 0.49) | −0.23 (−0.83, 0.37) | 0.19 (−0.72, 1.11) | p | <0.01 | 0.26 | 0.56 |
| ΔT3vsT1 | Mean (95% CI) | −0.06 (−0.60, 0.49) | −0.20 (−0.88, 0.47) | 0.09 (0.90, 1.08) | η2 | 0.50 | 0.07 | 0.04 | |
| ΔT4vsT1 | Mean (95% CI) | −0.41 (−0.94, 0.12) | −0.32 (−1.00, 0.36) | −0.51 (−1.47, 0.45) | 1-β | 0.98 | 0.35 | 0.19 | |
| IL-1β | T1 | Mean ± SD | 1.55 ± 0.62 | 1.60 ± 0.54 | 1.49 ± 0.71 | F | 5.39 | 0.10 | 0.46 |
| (pg/mL) | ΔT2vsT1 | Mean (95% CI) | −0.08 (−0.45, 0.28) | −0.03 (−0.62, 0.96) | −0.13 (−0.68, 0.42) | p | 0.03 | 0.96 | 0.71 |
| ΔT3vsT1 | Mean (95% CI) | 0.01 (−0.43, 0.45) | 0.17 (−0.62, 0.96) | −0.15 (−0.69, 0.39) | η2 | 0.23 | 0.01 | 0.03 | |
| ΔT4vsT1 | Mean (95% CI) | −0.02 (−0.46, 0.42) | 0.16 (−0.67, 0.98) | −0.20 (−0.69, 0.30) | 1-β | 0.59 | 0.07 | 0.14 | |
| IL-10 | T1 | Mean ± SD | 4.13 ± 1.79 | 4.30 ± 1.34 | 3.96 ± 2.21 | F | 0.13 | 2.24 | 0.06 |
| (pg/mL) | ΔT2vsT1 | Mean (95% CI) | −0.92 (−1.95, 0.12) | −1.11 (−2.75, 0.54) | −0.73 (−2.32, 0.87) | p | 0.72 | 0.09 | 0.98 |
| ΔT3vsT1 | Mean (95% CI) | −1.02 (−2.14, 0.10) | −1.14 (−2.64, 0.36) | −0.90 (−2.88, 1.08) | η2 | 0.01 | 0.11 | <0.01 | |
| ΔT4vsT1 | Mean (95% CI) | 0.04 (−1.56, 1.64) | 0.04 (−1.87, 1.96) | 0.04 (−2.96, 3.03) | 1-β | 0.06 | 0.54 | 0.06 |
SD: standard deviation, CI: confidence interval, T1: measurement before 1 WBC, T2: measurement after 12 WBC, T3: measurement after 24 WBC, T4: measurement 7 days after completing WBC treatments, ΔvsT1: difference in results for points T2, T3 and T4 vs. T1; CRP: C-reactive protein, IL-6: interleukin 6, IL-1β: interleukin 1β, IL-10: interleukin 10; * statistically significant difference (p < 0.05), η2: partial eta squared (0.010–0.059 = small clinical effect, 0.060–0.139 = moderate clinical effect, ≥ 0.14 = large clinical effect), 1-β: power of statistical test.